Overview

Safety and Efficacy of Lidoderm (Lidocaine Patch 5%) in Treating Moderate to Severe Pain Associated With Carpal Tunnel Syndrome

Status:
Terminated

Trial end date:
2007-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the analgesic efficacy and safety of the lidocaine patch 5% compared to placebo in patients with moderate to severe pain associated with carpal tunnel syndrome.

Phase:

Phase 3

Details

Lead Sponsor:

Endo Pharmaceuticals

Treatments:

Lidocaine